Southport Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-536
Closed -$41K 395
2018
Q3
$41K Buy
+536
New +$39.6K 0.02% 273
2016
Q3
Sell
-112
Closed -$8K 353
2016
Q2
$8K Buy
+112
New +$7.74K ﹤0.01% 434

Other funds holding NVS

Southport Capital Management's NVS Position: Q4 2018 in Review

Southport Capital Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 536 shares — an estimated $41K sold.

Southport Capital Management first reported a position in NVS in Q2 2016 and held it in 2 quarters. The position peaked at $41K in Q3 2018. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • Southport Capital Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • Southport Capital Management sold 536 Novartis shares in Q4 2018, an estimated $41K.
  • Southport Capital Management first reported a position in Novartis in Q2 2016 and held it in 2 quarters.
  • Southport Capital Management's Novartis position peaked at $41K in Q3 2018.
  • 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.